Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

PaperCitations, authors & open-access status

Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 296 citations, 2016 year and bronze oa status.

296
Citations
2016
Year
bronze
OA Status

Related on ScholarIQ

Anatole Besarab
Author
Clinical Journal of the American Society of Nephrology
Journal
Erythropoietin and Anemia Treatment
Topic
Erythropoietin and Anemia Treatment
Topic
Iron Metabolism and Disorders
Topic
Blood transfusion and management
Topic
470M+ articles · free account